Albert Labs International (XCNQ:ABRT) Change In Receivables : C$0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Change In Receivables?

Albert Labs International's change in receivables for the quarter that ended in Sep. 2023 was C$0.00 Mil. It means Albert Labs International's Accounts Receivable stayed the same from Jun. 2023 to Sep. 2023 .

Albert Labs International's change in receivables for the fiscal year that ended in Dec. 2022 was C$0.00 Mil. It means Albert Labs International's Accounts Receivable declined by C$0.00 Mil from Dec. 2021 to Dec. 2022 .

Albert Labs International's Accounts Receivable for the quarter that ended in Sep. 2023 was C$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Albert Labs International's liquidation value for the three months ended in Sep. 2023 was C$-0.51 Mil.

Albert Labs International Change In Receivables Historical Data

The historical data trend for Albert Labs International's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Change In Receivables Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Change In Receivables

0.15

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Receivables	Get a 7-Day Free Trial					-	-	-	-	-

Albert Labs International Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Albert Labs International (XCNQ:ABRT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Albert Labs International's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Albert Labs International's accounts receivable are only considered to be worth 75% of book value:

Albert Labs International's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0.508	+	0.75 * 0	+	0.5 * 0
=	-0.51

Albert Labs International Change In Receivables Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines